NVP-BEZ235 inhibits growth of ovarian cancer cells, increases survival: Study
 |
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson Comprehensive Cancer Center has found. ...
[suite]  0Commentaire(s)
|
Par : Moderateur : Asirem Le : 2011-04-17 à: 19:16:26
Alcohol-Dependence Impulsivity Linked To Brain Anomalies
 |
Researchers already know that alcohol dependence (AD) is strongly associated with impaired impulse control or, more precisely, the inability to choose large, delayed rewards rather than smaller but more immediate rewards. Findings from a study using functional magnetic resonance imaging (fMRI) to investigate the neural basis of impulsive choice among individuals with alcohol use disorders (AUDs) suggest that impulsive choice in AD may be the result of functional anomalies ...
[suite] 0Commentaire(s)
|
Par : Moderateur : Asirem Le : 2011-04-17 à: 19:09:54
Increased levels of plasma renin activity protein may predict major cardiovascular event in high-risk patients
 |
Increased levels of a protein that helps regulate the body's blood pressure may also predict a major cardiovascular event in high-risk patients, according to a study led by St. Michael's Hospital's cardiovascular surgeon Subodh Verma. Measuring the amount of the protein, known as plasma renin activity (PRA), ...
[suite] 0Commentaire(s)
|
Par : Moderateur : Asirem Le : 2011-04-10 à: 18:25:00
Progesterone reduces the risk of giving birth prematurely
 |
A national Intitutes of Health study on women with short cervix has found that progesterone gel reduces significantly the risk of giving birth before the 33rd week of pregnancy by 45% . The cervix is the part of the uterus that gets shorter and opens largely during labor to make passage to the bebay, while it's supposed to be long and closed before labor beggins. ...
[suite] 0Commentaire(s)
|
Par : Moderateur : Asirem Le : 2011-04-10 à: 18:21:00
Fibrate use, especially fenofibrate, on the rise despite questionable benefit
 |
Pomona, CA - The use of fibrates in the US has increased steadily over the past 10 years and remained consistent in Canada, with the market share dominated by brand-name fenofibrate over generic formulations, according to the results of a new analysis [1]. Investigators point out that the increased use of fibrates contrasts with results from clinical trials showing no benefit of fibrate therapy in diabetic patients already taking statins. ...
[suite] 0Commentaire(s)
|
Par : Moderateur : Asirem Le : 2011-03-28 à: 20:25:09
Obesity : "Apples" no worse than "pears" in terms of CV risk
 |
Cambridge, UK - A new study has cast doubt on the widely held belief that obesity in an apple shape, with fat accumulation around the stomach area, is more damaging in terms of cardiovascular risk than other types of obesity.
The study, published online in the Lancet on March 11, 2011, was conducted by the international group known as the Emerging Risk Factors Collaboration.
...
[suite] 0Commentaire(s)
|
Par : Moderateur : Asirem Le : 2011-03-15 à: 20:42:28
Long road ahead to achieve CV health as defined by AHA
 |
Pittsburgh, PA - The first attempt to apply the concept of "cardiovascular health"—as outlined in the American Heart Association's (AHA's) 2020 Impact Goal issued last year—to a cohort of middle-aged community-dwelling individuals in the US found that everyone has a very long way to go to reach this goal and that blacks in particular will find it most challenging ...
[suite] 0Commentaire(s)
|
Par : Moderateur : Asirem Le : 2011-02-21 à: 21:04:03
Don't give up on folic acid—it might work in primary prevention
 |
London, UK - A possible explanation for why lowering homocysteine with folic acid has not shown benefit in reducing ischemic events, when genetic studies appear to have identified homocysteine as a causal risk factor for heart disease ... ...
[suite] 0Commentaire(s)
|
Par : Moderateur : Asirem Le : 2011-02-09 à: 18:58:16
Canadian study affirms cancer risk from imaging
 |
Montreal, QC - Another registry study confirms that low-dose radiation from cardiac imaging raises a patient's risk of cancer [1].
Results from a cohort study of over 82 000 patients in the Quebec Med-Echo registry by Dr Mark Eisenberg (McGill University, Montreal, QC) and colleagues are published online February 7, 2011 in CMAJ...
...
[suite] 0Commentaire(s)
|
Par : Moderateur : Asirem Le : 2011-02-09 à: 18:51:43
FDA alert: Dronedarone and severe liver injury
 |
Silver Spring, MD - Sanofi-Aventis has sent US healthcare professionals a letter warning them about cases of rare but severe hepatic injury associated with use of the antiarrhythmic drug dronedarone (Multaq), the company has informed heartwire. In two instances, liver transplants had to be performed. ...
[suite] 0Commentaire(s)
|
Par : Moderateur : Asirem Le : 2011-01-14 à: 19:43:43
|
Question de la semaine 
Nos partenaires 
Home > Actualités médicales > Medical news